Zalups R K
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia, USA.
J Toxicol Environ Health A. 1998 Apr 24;53(8):615-36. doi: 10.1080/009841098159079.
Three sets of experiments were carried out to determine if there is an intestinal secretory component in the fecal excretion of administered inorganic mercury. In the first set of experiments the disposition of a nontoxic 0.5-micromol/kg intravenous dose of inorganic mercury was evaluated in control rats and rats whose bile duct had been ligated. Data collected 24 h after the administration of mercuric chloride indicated that some inorganic mercury had moved from the blood across the epithelium into the lumen of the stomach, small intestine, and large intestine. This secretory movement of mercury was most prominent in the small intestine. Interestingly, the renal uptake and accumulation of mercury were diminished significantly in the rats whose bile duct had been ligated. A time-course experiment showed that the maximum amount of secretory movement of mercury into the lumen of the small intestine occurred during the initial 12 h after the injection of mercuric chloride. By the end of 24 h after the injection of mercuric chloride, much of the inorganic mercury secreted in the small intestine appeared to have moved down into the large intestine. In a third experiment, the disposition of mercury was evaluated in control rats and rats who had their bile duct cannulated. The rationale for this third experiment was to study the disposition of mercury under conditions where obstruction of biliary outflow from the liver would not be as much of an issue as with ligation of the bile duct. Evidence for movement of mercury into the lumen of the intestines was also obtained from the rats whose bile duct had been ligated. Eighteen hours after the injection of mercuric chloride the amount of mercury in the luminal compartment of the small intestine was not statistically different between the two groups of rats. Approximately 1.7-2.1% of the administered dose was present in the luminal contents of the small intestine. Decreased renal uptake of mercury was also detected in the rats whose bile duct had been cannulated. The findings from the present study show that when bile flow is obstructed or diverted, clear evidence for secretory movement of mercury into the lumen of the gastrointestinal (GI) tract can be demonstrated. These findings also indicate that the secretory movement of mercury into the lumen of the GI tract is a mechanism that contributes significantly to the pool of mercury that is excreted in the feces.
进行了三组实验,以确定施用的无机汞在粪便排泄中是否存在肠道分泌成分。在第一组实验中,对对照大鼠和胆管已结扎的大鼠评估了静脉注射0.5微摩尔/千克无毒无机汞的处置情况。在注射氯化汞24小时后收集的数据表明,一些无机汞已从血液穿过上皮进入胃、小肠和大肠的管腔。汞的这种分泌性移动在小肠中最为明显。有趣的是,胆管已结扎的大鼠中汞的肾脏摄取和积累显著减少。一项时间进程实验表明,汞向小肠管腔分泌性移动的最大量发生在注射氯化汞后的最初12小时内。到注射氯化汞24小时结束时,小肠中分泌的许多无机汞似乎已向下移动到大肠。在第三个实验中,对对照大鼠和胆管已插管的大鼠评估了汞的处置情况。第三个实验的原理是研究在肝脏胆汁流出受阻程度不像胆管结扎那样严重的情况下汞的处置情况。从胆管已结扎的大鼠中也获得了汞进入肠管腔的证据。注射氯化汞18小时后,两组大鼠小肠管腔部分中的汞含量在统计学上没有差异。施用剂量的约1.7 - 2.1%存在于小肠的管腔内容物中。在胆管已插管的大鼠中也检测到汞的肾脏摄取减少。本研究的结果表明,当胆汁流动受阻或改道时,可以证明汞向胃肠道(GI)管腔分泌性移动的明确证据。这些发现还表明,汞向GI管腔的分泌性移动是一种对粪便中排泄的汞池有显著贡献作用的机制。